Evidence map›Paper›PMID 27338315›Full record

ArticleMolecules (Basel, Switzerland)2016

Optimization of Preparation Conditions for Lysozyme Nanoliposomes Using Response Surface Methodology and Evaluation of Their Stability.

Zhipan Wu, Rongfa Guan, Fei Lyu, Mingqi Liu, Jianguo Gao, Guozou Cao

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhipan WuNational & Local United Engineering Lab of Quality Controlling Technology and Instrumentation for Marine Food, China Jiliang University, Hangzhou 310018, China. wuzhipanjl@126.com.
Rongfa GuanNational & Local United Engineering Lab of Quality Controlling Technology and Instrumentation for Marine Food, China Jiliang University, Hangzhou 310018, China. Rongfaguan@163.com.
Fei LyuDepartment of Food Science, Ocean College, Zhejiang University of Technology, Hangzhou 310014, China. lvfei_zju@163.com.
Mingqi LiuNational & Local United Engineering Lab of Quality Controlling Technology and Instrumentation for Marine Food, China Jiliang University, Hangzhou 310018, China. mqliu524@163.com.
Jianguo GaoInspection and Quarantine Center of Shandong Exit & Entry Inspection and Quarantine Burean, Qingdao 266002, China. china.gjg@163.com.
Guozou CaoNingbo Inspection and Quarantine Institute of Science and Technology, Ningbo 315000, China. caogz@nbciq.gov.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main purpose of this study was to optimize the preparation of lysozyme nanoliposomes using response surface methodology and measure their stability. The stabilities of lysozyme nanoliposomes in simulated gastrointestinal fluid (SGF), simulated intestinal fluid (SIF), as well as pH, temperature and sonication treatment time were evaluated. Reverse-phase evaporation method is an easy, speedy, and beneficial approach for nanoliposomes' preparation and optimization. The optimal preparative conditions were as follows: phosphatidylcholine-to-cholesterol ratio of 3.86, lysozyme concentration of 1.96 mg/mL, magnetic stirring time of 40.61 min, and ultrasound time of 14.15 min. At the optimal point, encapsulation efficiency and particle size were found to be 75.36% ± 3.20% and 245.6 nm ± 5.2 nm, respectively. The lysozyme nanoliposomes demonstrated certain stability in SGF and SIF at a temperature of 37 °C for 4 h, and short sonication handling times were required to attain nano-scaled liposomes. Under conditions of high temperature, acidity and alkalinity, lysozyme nanoliposomes are unstable.

Indexed as

CholesterolLiposomesMuramidaseNanoparticlesParticle SizePhosphatidylcholinesSonicationSurface PropertiesCholesterolLiposomesMuramidasePhosphatidylcholineslysozymenanoliposomesoptimizationresponse surface methodologystability

Identifiers

PMID27338315
PMCPMC6273706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.